Status:
ACTIVE_NOT_RECRUITING
Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial
Lead Sponsor:
R-Bio
Conditions:
Knee Osteoarthritis
Eligibility:
All Genders
20+ years
Phase:
PHASE3
Brief Summary
The purpose of this follow-up study is to investigate the efficacy and safety of autologous Adipose Tissue derived Mesenchymal stem cells (JOINTSTEM®) in patient with severe Knee Osteoarthritis.
Eligibility Criteria
Inclusion
- Participants of Jointstem Phase 3 Clinical Trial
- Participates who signed informed consent document of this study
Exclusion
- No applicable
Key Trial Info
Start Date :
April 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2027
Estimated Enrollment :
129 Patients enrolled
Trial Details
Trial ID
NCT04427930
Start Date
April 13 2020
End Date
December 30 2027
Last Update
July 10 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Keimyung University Dongsan Medical Center
Daegu, South Korea, 42601
2
KyungHee University Gangdong Hospital
Seoul, South Korea, 05278
3
Gangnam Severance Hospital
Seoul, South Korea, 06273
4
The Catholic University of Korea, Seoul ST. Mary's Hospital
Seoul, South Korea, 06591